919-16-4
919-16-4
Chemical Structure
Lithium citrate
Synonym(s): Litarex
- CAS No.: 919-16-4
- Formula:C6H5Li3O7
- Molecular Weight:209.92
IUPAC Name: lithium 2-hydroxypropane-1,2,3-tricarboxylate
InChIKey: WJSIUCDMWSDDCE-UHFFFAOYSA-K
SMILES: O=C(CC(C(O[Li])=O)(CC(O[Li])=O)O)O[Li]
Biological Activity: Lithium citrate is a lithium supplement that reduces excess brain N-acetylaspartate (NAA) in Canavan disease. Canavan disease is an autosomal recessive leukodystrophy caused by mutations in the aspartate acylase (ASPA) gene, which catalyzes the hydrolysis of N-acetylaspartate (NAA) to acetate and aspartate[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Lithium citrate | 98.0% | Lithium citrate is a lithium supplement that reduces excess brain N-acetylaspartate (NAA) in Canavan disease. Canavan disease is an autosomal recessive leukodystrophy caused by mutations in the aspartate acylase (ASPA) gene, which catalyzes the hydrolysis of N-acetylaspartate (NAA) to acetate and aspartate. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
